About
Obstructive Sleep Apnoea
Dronabinol for OSA
Investors
More
Ty Burton
Director
Rich Purcell
Senior VP
Research & Development
Marc Radin
Controller
Arnold Lippa, Ph.D.
Acting Co-CEO and CSO
Jeffrey Witkin, Ph.D.
Senior Research Fellow
Jeff E. Margolis
Acting Co-CEO and CFO
Will Clodfelter
Business Development
Michael Burfield
Rok Cerne, Ph.D.
Partners and Professional Service Providers
iNGENu CRO Pty Ltd
Contract Research Organization
Ab Initio Pharma Pty Ltd.
Manufacturing, Formulation and Testing
RespireRx Pharmaceuticals Inc.
Management
R&D
Bentley’s SA/NT
Accounting
R&D Tax Incentive
DL Piper
Counsel
